BRIEF-MEI Pharma Highlights Recommendation By Leading Independent Proxy Advisory Firm ISS To Vote 'FOR' Pending Transaction With Infinity Pharmaceuticals

Reuters
05 Jul 2023

July 5 (Reuters) - MEI Pharma Inc :

* MEI PHARMA HIGHLIGHTS RECOMMENDATION BY LEADING INDEPENDENT PROXY ADVISORY FIRM ISS TO VOTE “FOR” PENDING TRANSACTION WITH INFINITY PHARMACEUTICALS

Source text for Eikon: Further company coverage:

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10